CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-18 | Sheridan William P Senior VP - CMO | Sale | −20,488 | $7.58 | $155K | 2,725 |
| 2018-12-10 | Powell Lynne Senior VP - CCO | Option exercise | +2,000 | $3.22 | $6K | 2,000 |
| 2018-12-10 | Powell Lynne Senior VP - CCO | Sale | −2,000 | $9.01 | $18K | 0 |
| 2018-12-10 | Powell Lynne Senior VP - CCO | Option exercise | +2,000 | $3.22 | $6K | 2,000 |
| 2018-12-10 | Powell Lynne Senior VP - CCO | Sale | −2,000 | $9.11 | $18K | 0 |
| 2018-12-10 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −2,000 | 99,427 | ||
| 2018-12-10 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −2,000 | 97,427 | ||
| 2018-12-04 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,922 | $9.45 | $37K | 133,461 |
| 2018-12-03 | Stonehouse Jon P President & CEO | Option exercise | +80,000 | $1.20 | $96K | 807,674 |
| 2018-12-03 | Stonehouse Jon P President & CEO | Sale | −80,000 | $9.12 | $730K | 727,674 |
| 2018-12-03 | Stonehouse Jon P President & CEO | Option exercise · Emp. Stock Option (Right to Buy) | −80,000 | 0 | ||
| 2018-12-03 | HEGGIE THERESA Director | Grant or award · Non-Qualified Stock Option | +30,000 | 30,000 | ||
| 2018-11-30 | Barnes Alane P Senior VP, Chief Legal Officer | Option exercise | +25,000 | $1.42 | $36K | 122,243 |
| 2018-11-30 | Barnes Alane P Senior VP, Chief Legal Officer | Sale | −44,290 | $9.07 | $402K | 77,953 |
| 2018-11-30 | Barnes Alane P Senior VP, Chief Legal Officer | Option exercise · Emp. Stock Option (Right to Buy) | −25,000 | 25,000 | ||
| 2018-11-28 | Erck Stanley C Director | Option exercise | +8,333 | $1.49 | $12K | 48,333 |
| 2018-11-28 | Erck Stanley C Director | Option exercise · Non-Qualified Stock Option | −8,333 | 0 | ||
| 2018-11-23 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +3,500 | $3.78 | $13K | 140,883 |
| 2018-11-23 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,500 | $9.66 | $34K | 137,383 |
| 2018-11-23 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −3,500 | 28,305 |
Page 32 of 38 · 750 trades